Why Does Zepbound Make You Constipated? Understanding the Connection

Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (tirzepatide) works by slowing gastric emptying and reducing appetite signals in your brain—but that same mechanism that helps you eat less can also slow your entire digestive system. Constipation affects roughly 20-30% of GLP-1 users, making it one of the most frequently reported side effects during the first weeks of treatment. PlexusDx helps you stay on track by offering personalized tirzepatide injection therapy at $289/mo month-to-month, or from $249/mo on the 6-month plan, paired with practical strategies to prevent and manage constipation.

How GLP-1 Medications Slow Digestion

GLP-1 receptor agonists like tirzepatide are designed to delay how quickly food moves from your stomach into your small intestine—a process called gastric emptying. This slowdown keeps you feeling full longer and reduces hunger signals, which is why these medications are so effective for weight loss. However, the same delayed gastric transit that suppresses appetite also affects your colon's natural muscle contractions, leading to infrequent or difficult bowel movements.

Your gastrointestinal tract relies on rhythmic muscle contractions called peristalsis to move stool through your digestive system. When tirzepatide activates GLP-1 receptors in your gut, it reduces the frequency and strength of these contractions, essentially putting your bowels into a slower gear. This effect is dose-dependent, meaning constipation may worsen as your dose increases—though PlexusDx pricing stays flat regardless of dose level, so you can adjust your therapy without worrying about surprise costs.

Why Constipation Happens in the First Few Weeks

Most patients experience constipation during the first 2-4 weeks of starting Zepbound or compounded tirzepatide, when their bodies are adapting to the medication. Your gut microbiome and digestive rhythm take time to rebalance, and reduced food intake (from appetite suppression) means less bulk moving through your system, which naturally leads to fewer and harder stools. Studies show that side effects like constipation tend to peak around week 2-3, then gradually improve as your body tolerates the medication.

The PlexusDx Precision Peptide Genetic Test analyzes MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Zepbound or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Evidence-Based Strategies to Prevent and Manage GLP-1 Constipation

The first line of defense is increasing your daily water intake to at least 80-100 ounces per day, since dehydration makes stool harder and constipation worse. Pair this with a high-fiber diet—aiming for 30+ grams per day from vegetables, fruits, legumes, and whole grains—to add bulk to your stools and stimulate your bowels naturally. Over-the-counter stool softeners like docusate sodium (Colace) are safe to use during GLP-1 therapy and work by increasing water content in stool without causing cramping.

Moderate physical activity, such as 20-30 minutes of walking after meals, can help stimulate intestinal motility and improve bowel regularity. If these behavioral strategies don't work within 1-2 weeks, osmotic laxatives like polyethylene glycol (Miralax) are considered first-line pharmacological treatment and are compatible with tirzepatide. Avoid stimulant laxatives (senna, bisacodyl) as a first choice, since they can cause cramping and may become habit-forming with long-term use. Your PlexusDx provider can recommend specific over-the-counter products and help you adjust your medication dose if constipation becomes severe.

When to Contact Your PlexusDx Provider About Constipation

Mild constipation that improves with increased hydration and fiber is normal and usually resolves within 4 weeks of starting tirzepatide. However, you should reach out to your PlexusDx provider if constipation persists beyond 3 weeks despite home remedies, causes severe abdominal pain or bloating, or results in bowel obstruction symptoms like nausea and vomiting. In rare cases, persistent constipation may signal the need to lower your dose, switch to a different GLP-1 agent (such as semaglutide), or use a combination therapy like PlexusDx's GLP-Squared Injection.

PlexusDx's flat monthly pricing model ($289/month for tirzepatide injection, regardless of dose) means you can safely work with your provider to find your optimal dose without financial penalties. If you haven't had a bowel movement in more than 3 days or experience severe cramping, contact your provider before continuing treatment. Your goal is sustainable weight loss, not white-knuckle adherence to a medication that's causing intolerable side effects.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is constipation a sign that tirzepatide isn't right for me?

No—constipation is a predictable, manageable side effect of GLP-1 medications, not a sign of treatment failure. Most patients experience mild constipation for 2-4 weeks as their gut adapts, then resolve it with hydration, fiber, and light physical activity. If constipation persists severely, your PlexusDx provider can adjust your dose or suggest alternative medications, but temporary constipation should not discourage you from continuing therapy.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and identifies genetic variants in MC4R genes that influence how your body responds to GLP-1 medications. Patients with certain genetic profiles may experience more pronounced gastrointestinal side effects and may benefit from a lower starting dose or additional dietary support. The test costs $298.

Can I use laxatives safely while taking Zepbound?

Yes—stool softeners (docusate) and osmotic laxatives (polyethylene glycol/Miralax) are safe to use with tirzepatide and are often recommended as first-line treatments for GLP-1-related constipation. Avoid stimulant laxatives initially, as they can cause cramping and dependence. Always inform your PlexusDx provider about any over-the-counter medications or supplements you're using to ensure they don't interact with your treatment.

Does constipation mean my tirzepatide dose is too high?

Not necessarily—mild constipation is common even at the lowest effective doses. However, if constipation is severe and unmanageable with hydration and fiber, it may signal that your dose needs adjustment. The good news is that PlexusDx pricing is flat at $289/month for tirzepatide injection, so your provider can lower your dose without any cost change, making it easier to find your personal sweet spot.

How long does GLP-1 constipation typically last?

Most patients experience constipation for 2-4 weeks when starting tirzepatide, with symptoms peaking around week 2-3 and gradually improving as their body adapts. If constipation persists beyond 4 weeks despite aggressive dietary and lifestyle measures, contact your PlexusDx provider to discuss dose adjustment or alternative GLP-1 options like semaglutide injection or oral tirzepatide.

Related Reading

• Fridays Zepbound
• Hims Zepbound
• Form Health Zepbound
• Brello Zepbound

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.